* TEVA ANNOUNCES UPSIZING AND SUCCESSFUL PRICING OF $4.5 BILLION OF SENIOR NOTES

* TEVA PHARMACEUTICAL INDUSTRIES - ‍NOTE OFFERING WAS UPSIZED FROM A PREVIOUSLY ANNOUNCED AMOUNT OF $3.5 BILLION​

* TEVA - ‍NET PROCEEDS FROM NOTES EXPECTED TO BE USED TO REPAY ABOUT $2.3 BILLION INDEBTEDNESS UNDER U.S. DOLLAR AND JAPANESE YEN TERM LOAN AGREEMENTS​ Source text for Eikon: Further company coverage: